Literature DB >> 12631656

Aspirin inhibits the growth of Helicobacter pylori and enhances its susceptibility to antimicrobial agents.

W H Wang1, W M Wong, D Dailidiene, D E Berg, Q Gu, K C Lai, S K Lam, B C Y Wong.   

Abstract

BACKGROUND AND AIM: The role of Helicobacter pylori and aspirin in peptic ulcer formation and recurrence remains an important clinical topic. The interaction between aspirin and H pylori in vitro is also not clear. We investigated the effect of aspirin on the growth of H pylori and on the susceptibility of H pylori to antimicrobials.
METHODS: Time killing studies of H pylori were performed with different concentrations of aspirin and salicylate. Growth of bacteria was assessed spectrophotometrically and by viable colony count. The effects of aspirin on the efficiency of colony formation and on metronidazole induced mutation to rifampicin resistance in H pylori were determined. Minimal inhibitory concentrations (MICs) of aspirin and metronidazole were tested by the standard agar dilution method. MICs of amoxycillin and clarithromycin were determined by the E test method.
RESULTS: Aspirin and salicylate inhibited the growth of H pylori in a dose dependent manner and bactericidal activity was due to cell lysis. Aspirin 400 micro g/ml caused a 2 logs decrease in colony forming units/ml at 48 hours, and suppressed the normal ability of metronidazole to induce new mutations to rifampicin. The IC(90) of aspirin was 512 micro g/ml. Increased susceptibility of amoxycillin, clarithromycin, and metronidazole to H pylori was observed at 1 mM (180 micro g/ml) aspirin.
CONCLUSIONS: Aspirin inhibited the growth of H pylori, suppressed the mutagenic effect of metronidazole, and enhanced the susceptibility of H pylori to antimicrobial agents. This mechanism is important in future drug development for effective clearing and overcoming resistance.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12631656      PMCID: PMC1773581          DOI: 10.1136/gut.52.4.490

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  40 in total

1.  Changes in Helicobacter pylori ultrastructure and antigens during conversion from the bacillary to the coccoid form.

Authors:  M Benaissa; P Babin; N Quellard; L Pezennec; Y Cenatiempo; J L Fauchère
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

2.  Antimicrobial activities of N-acetylcysteine and some non-steroidal antiinflammatory drugs.

Authors:  H Cederlund; P A Mårdh
Journal:  J Antimicrob Chemother       Date:  1993-12       Impact factor: 5.790

3.  Lidocaine hydrochloride and acetylsalicylate kill bacteria by disrupting the bacterial membrane potential in different ways.

Authors:  S Ohsuka; M Ohta; K Masuda; Y Arakawa; T Kaneda; N Kato
Journal:  Microbiol Immunol       Date:  1994       Impact factor: 1.955

4.  Salicylate induction of antibiotic resistance in Escherichia coli: activation of the mar operon and a mar-independent pathway.

Authors:  S P Cohen; S B Levy; J Foulds; J L Rosner
Journal:  J Bacteriol       Date:  1993-12       Impact factor: 3.490

5.  The coccoid forms of Helicobacter pylori. Criteria for their viability.

Authors:  G Bode; F Mauch; P Malfertheiner
Journal:  Epidemiol Infect       Date:  1993-12       Impact factor: 2.451

6.  Effect of Helicobacter pylori colonisation on gastric mucosal eicosanoid synthesis in patients taking non-steroidal anti-inflammatory drugs.

Authors:  N Hudson; M Balsitis; F Filipowicz; C J Hawkey
Journal:  Gut       Date:  1993-06       Impact factor: 23.059

7.  Helicobacter pylori requires an acidic environment to survive in the presence of urea.

Authors:  M Clyne; A Labigne; B Drumm
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

8.  Virulence of coccoid and bacillary forms of Helicobacter pylori in gnotobiotic piglets.

Authors:  K A Eaton; C E Catrenich; K M Makin; S Krakowka
Journal:  J Infect Dis       Date:  1995-02       Impact factor: 5.226

9.  Interaction of NSAIDs and Helicobacter pylori on gastrointestinal injury and prostaglandin production: a controlled double-blind trial.

Authors:  L Laine; F Cominelli; R Sloane; V Casini-Raggi; M Marin-Sorensen; W M Weinstein
Journal:  Aliment Pharmacol Ther       Date:  1995-04       Impact factor: 8.171

10.  Factors affecting growth and antibiotic susceptibility of Helicobacter pylori: effect of pH and urea on the survival of a wild-type strain and a urease-deficient mutant.

Authors:  J E Sjöström; H Larsson
Journal:  J Med Microbiol       Date:  1996-06       Impact factor: 2.472

View more
  28 in total

1.  Chitosan-EDTA new combination is a promising candidate for treatment of bacterial and fungal infections.

Authors:  Amany A El-Sharif; Mohamed H M Hussain
Journal:  Curr Microbiol       Date:  2010-10-21       Impact factor: 2.188

Review 2.  Antibiotic resistance breakers: can repurposed drugs fill the antibiotic discovery void?

Authors:  David Brown
Journal:  Nat Rev Drug Discov       Date:  2015-10-23       Impact factor: 84.694

3.  Down regulation of virulence factors of Pseudomonas aeruginosa by salicylic acid attenuates its virulence on Arabidopsis thaliana and Caenorhabditis elegans.

Authors:  B Prithiviraj; H P Bais; T Weir; B Suresh; E H Najarro; B V Dayakar; H P Schweizer; J M Vivanco
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

Review 4.  Antimicrobial Effects of Antipyretics.

Authors:  Petra Zimmermann; Nigel Curtis
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

5.  Benzoate- and Salicylate-Tolerant Strains of Escherichia coli K-12 Lose Antibiotic Resistance during Laboratory Evolution.

Authors:  Kaitlin E Creamer; Frederick S Ditmars; Preston J Basting; Karina S Kunka; Issam N Hamdallah; Sean P Bush; Zachary Scott; Amanda He; Stephanie R Penix; Alexandra S Gonzales; Elizabeth K Eder; Dominic W Camperchioli; Adama Berndt; Michelle W Clark; Kerry A Rouhier; Joan L Slonczewski
Journal:  Appl Environ Microbiol       Date:  2016-12-30       Impact factor: 4.792

6.  In vitro interactions between aspirin and amphotericin B against planktonic cells and biofilm cells of Candida albicans and C. parapsilosis.

Authors:  Yabin Zhou; Ganggang Wang; Yutang Li; Yang Liu; Yu Song; Wenshuai Zheng; Ning Zhang; Xiaoyan Hu; Shikun Yan; Jihui Jia
Journal:  Antimicrob Agents Chemother       Date:  2012-03-05       Impact factor: 5.191

7.  Celecoxib inhibits Helicobacter pylori colonization-related factors.

Authors:  Jing Wang; Wei-Hong Wang; Jiang Li; Fang-Xun Liu
Journal:  World J Gastroenterol       Date:  2010-02-21       Impact factor: 5.742

8.  Effect of high-dose aspirin on Helicobacter pylori eradication.

Authors:  Seung Ha Park; Dong Il Park; Sang Hoon Kim; Hong Joo Kim; Yong Kyun Cho; In Kyung Sung; Chong Il Sohn; Woo Kyu Jeon; Byung Ik Kim; Dong Keuk Keum
Journal:  Dig Dis Sci       Date:  2005-04       Impact factor: 3.199

9.  Nimesulide inhibits pathogenic fungi: PGE2-dependent mechanisms.

Authors:  Rafaelle Fonseca de Matos; Lúcia Carla Vasconcelos Mendonça; Kaira Geiliane da Silva Souza; Adriana Aparecida Durães Fonseca; Elaine Mirla Souza Costa; Marcus Vinicius Dias de Lima; José Maria Dos Santos Vieira; Mioni Thielli Figueiredo Magalhães de Brito; Marta Chagas Monteiro
Journal:  Folia Microbiol (Praha)       Date:  2016-11-19       Impact factor: 2.099

Review 10.  The anti-inflammatory non-antibiotic helper compound diclofenac: an antibacterial drug target.

Authors:  K Mazumdar; S G Dastidar; J H Park; N K Dutta
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-04-28       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.